Pengaruh Praktik Corporate Governance dan Prinsip Konservatisme Terhadap Manajemen Laba (Study Empiris pada Perusahaan Manufaktur yang Terdaftar di Bursa Efek Indonesia)
EKASAKTI PARESO JURNAL AKUNTANSI · 2023
DOI: 10.31933/epja.v1i3.908 ↗Kurz gefasst
Fachartikel in der Zeitschrift EKASAKTI PARESO JURNAL AKUNTANSI, 2023. Verfasst von Hasnawati Ramsah und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In this study, the multiple linear regression method was used for data analysis. The purpose of this study was to analyze the impact of institutional ownership, management ownership, independent commissioners, audit committees, and conservatism on financial management. The subjects of this research are companies listed on the Indonesia Stock Exchange for the period 2018-2019 in the manufacturing category. And obtained 23 research samples using the purposive sampling method. The results of this study indicate that institutional ownership, management, independent commissioners, audit committees, and conservatism do not affect profit management.
Zitieren
APA
Ramsah, H., Sutarjo, A., & Yani, M. (2023). Pengaruh Praktik Corporate Governance dan Prinsip Konservatisme Terhadap Manajemen Laba (Study Empiris pada Perusahaan Manufaktur yang Terdaftar di Bursa Efek Indonesia). EKASAKTI PARESO JURNAL AKUNTANSI. https://doi.org/10.31933/epja.v1i3.908
Vancouver
Ramsah H, Sutarjo A, Yani M. Pengaruh Praktik Corporate Governance dan Prinsip Konservatisme Terhadap Manajemen Laba (Study Empiris pada Perusahaan Manufaktur yang Terdaftar di Bursa Efek Indonesia). EKASAKTI PARESO JURNAL AKUNTANSI. 2023. doi:10.31933/epja.v1i3.908
BibTeX
@article{Ramsah2023,
author = {Ramsah, Hasnawati and Sutarjo, Agus and Yani, Meri},
title = {Pengaruh Praktik Corporate Governance dan Prinsip Konservatisme Terhadap Manajemen Laba (Study Empiris pada Perusahaan Manufaktur yang Terdaftar di Bursa Efek Indonesia)},
journal = {EKASAKTI PARESO JURNAL AKUNTANSI},
year = {2023},
doi = {10.31933/epja.v1i3.908}
}
EUVIMED